These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3886255)

  • 1. Kinetics of methylprednisolone and its hemisuccinate ester.
    Derendorf H; Möllmann H; Rohdewald P; Rehder J; Schmidt EW
    Clin Pharmacol Ther; 1985 May; 37(5):502-7. PubMed ID: 3886255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs.
    Toutain PL; Koritz GD; Fayolle PM; Alvinerie M
    J Pharm Sci; 1986 Mar; 75(3):251-5. PubMed ID: 3517294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid method for the measurement of methylprednisolone and its hemisuccinate in plasma and urine following "pulse therapy" by high-performance liquid chromatography.
    Lawson GJ
    J Chromatogr; 1985 Aug; 342(2):251-60. PubMed ID: 3902861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolysis of methylprednisolone hemisuccinate to methylprednisolone by a nonspecific carboxylesterase.
    Oshima T; Nakajima E; Hattori K
    Pharmacol Res Commun; 1980 Feb; 12(2):139-46. PubMed ID: 6992149
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of methylprednisolone in cat plasma and spinal cord following a single intravenous dose of the sodium succinate ester.
    Braughler JM; Hall ED
    Drug Metab Dispos; 1982; 10(5):551-2. PubMed ID: 6128209
    [No Abstract]   [Full Text] [Related]  

  • 7. Placental transfer of methylprednisolone following maternal intravenous administration.
    Anderson GG; Rotchell Y; Kaiser DG
    Am J Obstet Gynecol; 1981 Jul; 140(6):699-701. PubMed ID: 7020419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma.
    Kong AN; Slaughter RL; Jusko WJ
    J Chromatogr; 1988 Nov; 432():308-14. PubMed ID: 3065346
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic assay for methylprednisolone and its soluble prodrug esters in dog plasma.
    Shah JA; Weber DJ
    J Chromatogr; 1985 Nov; 344():41-9. PubMed ID: 3910669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal and oral absorption of methylprednisolone acetate.
    Garg DC; Wagner JG; Sakmar E; Weidler DJ; Albert KS
    Clin Pharmacol Ther; 1979 Aug; 26(2):232-9. PubMed ID: 455892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of route of administration on the pharmacokinetics of methylprednisolone.
    Antal EJ; Wright CE; Gillespie WR; Albert KS
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):561-76. PubMed ID: 6678310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies in the design of solution-stable, water-soluble prodrugs III: influence of the pro-moiety on the bioconversion of 21-esters of corticosteroids.
    Anderson BD; Conradi RA; Spilman CH; Forbes AD
    J Pharm Sci; 1985 Apr; 74(4):382-7. PubMed ID: 3889274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.
    Möllmann H; Rohdewald P; Barth J; Verho M; Derendorf H
    Biopharm Drug Dispos; 1989; 10(5):453-64. PubMed ID: 2804250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.
    Ebling WF; Szefler SJ; Jusko WJ
    J Chromatogr; 1984 Feb; 305(2):271-80. PubMed ID: 6368578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and elimination of methylprednisolone from contused cat spinal cord following intravenous injection of the sodium succinate ester.
    Braughler JM; Hall ED
    J Neurosurg; 1983 Apr; 58(4):538-42. PubMed ID: 6338168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.